Claims are without merit says start-up
California | 08 February 2015

Start-up Twist Bioscience has called allegations its CEO stole trade secrets and used them to co-found the company “baseless and without merit”.

Agilent Technologies has accused Twist CEO Emily Leproust of stealing synthetic gene manufacturing trade secrets when she left the company and set up her new venture.

Leproust worked at Agilent for 13 years as a scientist. When she left the company, a number of employees left with her, allegedly violating an agreement she had with Agilent, according to court documents.

Agilent’s complaint, filed on 3 February at the Superior Court of California, also claimed Twist’s success is due to “stolen” proprietary gene technology.

Agilent wants damages and an injunction against Twist, barring it from using the allegedly stolen knowledge.

Twist said in response that it intends to “defend itself vigorously” and Agilent’s actions reveal an “obvious attempt to stifle competition”.

Author: Tammy Facey



More IPPro Life Sciences | latest news
AstraZeneca enters China with Plendil
Hogan Lovells boosts capabilities in Japan
Morgan Lewis bags four from K&L Gates
Cobra and CPI enter £1.8 million project
Doctors Without Borders urges lower vaccine prices
IPPro Life Sciences
IPPRO ARCHIVES
BACK ISSUES ONLINE
COMPANY INFO
ABOUT US

THE TEAM


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization